Rafoxanide and Closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains

Mubarak Abdulrahman M Alamri, Hachemi Kadri, Luke Alderwick, Nigel Simpkins, Youcef Mehellou

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)
236 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Rafoxanide and Closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry